Related News for ケイファーマ

K Pharma Inc. (4896), a biotech venture originating from Keio University, has released i

K Pharma (4896) has released its latest financial results, reporting an operating loss of 471 million yen, an ordinary loss of 484 million yen, and a net loss of 492 million yen. Earnings per share (E